Corcept Therapeutics's operating cash flow per share for the
three
months ended in Dec. 2023 was $0.05.
Corcept Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.14.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Corcept Therapeutics was 9.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -2.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 2.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Corcept Therapeutics's Operating Cash Flow per Share or its related term are showing as below:
CORT'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -4.4 Med: 6.3 Max: 215.8
Current: -2.4
During the past 13 years, Corcept Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 215.80% per year. The lowest was -4.40% per year. And the median was 6.30% per year.
CORT's 3-Year OCF Growth Rate is ranked worse than 57.61% of 1236
companies
in the Biotechnology industry
Industry Median: 3.5
vs CORT: -2.40
Corcept Therapeutics Operating Cash Flow per Share Historical Data
The historical data trend for Corcept Therapeutics's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Corcept Therapeutics Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Operating Cash Flow per Share
1.11
1.22
1.33
1.04
1.14
Corcept Therapeutics Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Operating Cash Flow per Share
0.29
0.23
0.39
0.48
0.05
Competitive Comparison
For the Biotechnology subindustry, Corcept Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corcept Therapeutics Price-to-Operating-Cash-Flow Distribution
For the Biotechnology industry and Healthcare sector, Corcept Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Corcept Therapeutics's Price-to-Operating-Cash-Flow falls into.
Corcept Therapeutics Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Corcept Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corcept Therapeutics Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Corcept Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Corcept Therapeutics (Corcept Therapeutics) Business Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CORT has been successfully added to your 